Physician profile
Jay R Hsu
NPI 1386703023
$846.93
in general payments reported to CMS, 2019-2025
10 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.87 · 2021: $319 · 2022: $29.28 · 2023: $37.32 · 2024: $205 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $168.98 | 2021 | |
| Philips North America LLC | $162.96 | 2024-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, Extended Holter |
| Abiomed | $149.99 | 2021 | |
| Inspire Medical Systems, INC. | $119.24 | 2025 | Inspire |
| Pfizer INC. | $80.04 | 2023-2024 | |
| Boston Scientific Corporation | $65.62 | 2019-2024 | Clik X |
| Novartis Pharmaceuticals Corporation | $46.03 | 2022-2023 | |
| Irhythm Technologies, INC. | $21.50 | 2024 | Zio Monitor, Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $17.26 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.31 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.